- Report
- August 2025
- 190 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- January 2025
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- October 2024
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 188 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 195 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- September 2025
- 193 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 194 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- February 2025
- 182 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- May 2025
- 110 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- May 2025
- 114 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- March 2025
- 191 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- August 2025
- 150 Pages
Global
From €2961EUR$3,358USD£2,563GBP
€3484EUR$3,950USD£3,016GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- May 2025
- 93 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- January 2025
- 210 Pages
Global
From €4405EUR$4,995USD£3,814GBP

Desflurane is a volatile anesthetic drug used in the induction and maintenance of general anesthesia. It is a halogenated ether, and is one of the most commonly used inhalational anesthetics in modern clinical practice. Desflurane is a colorless liquid at room temperature, with a boiling point of 23.5°C. It has a low blood/gas partition coefficient, meaning it is rapidly eliminated from the body, and has a low solubility in blood, making it suitable for use in rapid-sequence induction. Desflurane is also known for its low incidence of postoperative nausea and vomiting.
Desflurane is available in a variety of formulations, including premixed solutions, vaporizers, and inhalers. It is manufactured by several companies, including Baxter, Hospira, and AbbVie. Other companies involved in the production and distribution of desflurane include B. Braun, Fresenius Kabi, and Merck. Show Less Read more